Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Drug Resistance Pattern Of Mycobacterium

Tuberculosis (TB) is the second most common cause of death due to an infectious disease. Among all new TB cases notified to federal ministry of health, 30% were smear positive. Among re-treatment cases 64%, 11% and 13% were relapse, treatment after failure, and treatment after default respectively. The directly observed treatment short course detection rate remains low, at 34%, compared with WHO™s target of 70%. The emergence and spread of DR-TB strains on new and previously treated cases have been a global threat. Worldwide, 3.7% of new cases and 20% of previously treated cases were estimated to have multi drug resistance-tuberculosis (MDR-TB). Extensively drugresistant tuberculosis (XDR- TB) has been reported in more than 70 countries. The proportion of MDR-TB patients who successfully completed treatment and cured were lowered than drug susceptible forms of TB. MDR-TB associated deaths were more worsen in the African Region (19%), where many of the diagnostic and treatment facilities were limited or totally absent.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on January, 2021